World's Best Scientists 2026 revealed!
Daniela Pende

Daniela Pende

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 92 1006 915 32 30 221 30813
Medicine 92 11314 10635 417 398 221 30813

Daniela Pende publications per year

The chart shows the history of publications by Daniela Pende between 1983 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Daniela Pende published across 43 years, from 1983 to 2025, averaging 6.4 papers a year. Output peaked at 54 publications in 2023. 6 of the 277 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1983 to 2025. Vertical axis: number of publications, 0 to 54. Peak 54 publications in 2023. 1983: 3 publications 1984: 3 publications 1985: 1 publication 1986: 6 publications 1987: 5 publications 1988: 2 publications 1989: 4 publications 1990: 5 publications 1991: 4 publications 1992: 6 publications 1993: 1 publication 1994: 2 publications 1995: 5 publications 1996: 7 publications 1997: 4 publications 1998: 5 publications 1999: 5 publications 2000: 2 publications 2001: 7 publications 2002: 5 publications 2003: 4 publications 2004: 8 publications 2005: 8 publications 2006: 11 publications 2007: 8 publications 2008: 4 publications 2009: 11 publications 2010: 6 publications 2011: 7 publications 2012: 5 publications 2013: 5 publications 2014: 8 publications 2015: 10 publications 2016: 7 publications 2017: 6 publications 2018: 6 publications 2019: 9 publications 2020: 3 publications 2021: 6 publications 2022: 3 publications 2023: 54 publications 2024: 1 publication 2025: 5 publications
1983 2025

277 publications in total across all disciplines

View publications per year as a table
Daniela Pende: publications per year, 1983 to 2025
Year Publications
1983 3
1984 3
1985 1
1986 6
1987 5
1988 2
1989 4
1990 5
1991 4
1992 6
1993 1
1994 2
1995 5
1996 7
1997 4
1998 5
1999 5
2000 2
2001 7
2002 5
2003 4
2004 8
2005 8
2006 11
2007 8
2008 4
2009 11
2010 6
2011 7
2012 5
2013 5
2014 8
2015 10
2016 7
2017 6
2018 6
2019 9
2020 3
2021 6
2022 3
2023 54
2024 1
2025 5
Total 277
Download as CSV

Daniela Pende publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniela Pende sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 212–221 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 221 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158 221
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Daniela Pende D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniela Pende sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72 92
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Daniela Pende is affiliated with the University of Genoa in Italy and has contributed to research primarily focused on immunology, hematology, and oncology. Their work spans topics such as immune cell function, T-cell and B-cell immunology, and hematopoietic stem cell transplantation, among others.

The scientist has published extensively in the fields of Immunology and Microbiology as well as Medicine. Their subfields of study include Immunology, Hematology, and Oncology. Research areas covered by their publications emphasize:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • IL-33, ST2, and ILC Pathways
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Autoimmune and Inflammatory Disorders Research
  • Immunotherapy and Immune Responses

The recent papers authored or co-authored by Daniela Pende demonstrate contributions to both immunotherapy and transplantation research. Highlights include:

  • "NK cells and ILCs in tumor immunotherapy," 2020, Molecular Aspects of Medicine
  • "Human NK cells, their receptors and function," 2021, European Journal of Immunology
  • "Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer," 2020, Frontiers in Immunology
  • "TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders," 2021, Blood Advances
  • "TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis," 2023, Blood

Daniela Pende's collaboration network includes frequent co-authors such as Lorenzo Moretta, Maria Cristina Mingari, Michela Falco, Raffaella Meazza, and Simona Sivori. The scientist has contributed multiple papers alongside these colleagues, reflecting sustained collaborative research efforts.

Publications by Daniela Pende are commonly found in specialized journals including Frontiers in Immunology, Blood Advances, Blood, HLA, and Molecular Aspects of Medicine. These venues align with their focus on immunological and hematological research domains.

Best Publications

  • Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

    Cristina Bottino;Roberta Castriconi;Daniela Pende;Paola Rivera

  • RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS

    Alessandro Moretta;Cristina Bottino;Massimo Vitale;Daniela Pende

  • Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

    Daniela Pende;Silvia Parolini;Anna Pessino;Simona Sivori

  • Major Histocompatibility Complex Class I-related Chain A and UL16-Binding Protein Expression on Tumor Cell Lines of Different Histotypes Analysis of Tumor Susceptibility to NKG2D-dependent Natural Killer Cell Cytotoxicity

    Daniela Pende;Paola Rivera;Stefania Marcenaro;Chien Chung Chang

  • Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

    Loredana Ruggeri;Antonella Mancusi;Marusca Capanni;Elena Urbani

  • NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

    Simona Sivori;Daniela Pende;Cristina Bottino;Emanuela Marcenaro

  • Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

    Régis T. Costello;Simona Sivori;Emanuela Marcenaro;Marina Lafage-Pochitaloff

  • Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

    A Moretta;C Bottino;D Pende;G Tripodi

  • Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

    Alessandro Moretta;Simona Sivori;Massimo Vitale;Daniela Pende

  • The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

    D Pende;R Biassoni;C Cantoni;S Verdiani

  • Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

    Daniela Pende;Stefania Marcenaro;Michela Falco;Stefania Martini

  • Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).

    Daniela Pende;Grazia Maria Spaggiari;Stefania Marcenaro;Stefania Martini

  • NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor

    Massimo Vitale;Mariella Della Chiesa;Simona Carlomagno;Daniela Pende

  • HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

    Alice Bertaina;Pietro Merli;Sergio Rutella;Sergio Rutella;Daria Pagliara

  • Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

    Daniela Pende;Claudia Cantoni;Claudia Cantoni;Paola Rivera;Massimo Vitale

  • HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

    Ennio Carbone;Paola Neri;Maria Mesuraca;Mariateresa T. Fulciniti

  • Human natural killer cell receptors and co‐receptors

    Roberto Biassoni;Claudia Cantoni;Claudia Cantoni;Daniela Pende;Simona Sivori;Simona Sivori

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes

    Alessandro Moretta;Roberto Biassoni;Cristina Bottino;Daniela Pende

Frequent Co-Authors

Lorenzo Moretta
Lorenzo Moretta Bambino Gesù Children's Hospital
Alessandro Moretta
Alessandro Moretta University of Genoa
Cristina Bottino
Cristina Bottino University of Genoa
Maria Cristina Mingari
Maria Cristina Mingari University of Genoa
Michela Falco
Michela Falco Istituto Giannina Gaslini
Massimo Vitale
Massimo Vitale University of Genoa
Claudia Cantoni
Claudia Cantoni University of Genoa
Simona Sivori
Simona Sivori University of Genoa
Roberto Biassoni
Roberto Biassoni Istituto Giannina Gaslini
Maurizio Aricò
Maurizio Aricò Azienda USL di Pescara

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, many of which increasingly intersect with nursing and advanced practice roles. For those interested in clinical applications, transitioning to specialized fields such as acute patient care is vital. Programs like acute care nurse practitioner programs offer a pathway for nurse practitioners to deepen their expertise in managing critical conditions, complementing an immunology background.

For students without a nursing foundation, pursuing an online Bachelor of Science in Nursing (BSN) is a practical starting point. Several online BSN programs for non nurses provide flexible and accessible options to enter the nursing field.

Speeding up this educational journey is possible through accelerated BSN programs for non nurses, designed to help career changers or recent graduates fast-track their credentials. Building on the BSN, aspiring practitioners can explore accelerated NP program options to swiftly advance toward becoming nurse practitioners, potentially integrating immunological expertise into patient care.

By combining immunology studies with these nursing pathways, graduates can enhance their career flexibility and contribute meaningfully to both research and frontline healthcare.

Best Scientists Citing Daniela Pende

Trending Scientists

Recently Published Articles